Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 2.260
+0.200 (9.71%)
Jul 16, 2025, 4:08 PM HKT
Broncus Holding Market Cap
Broncus Holding has a market cap or net worth of 1.19 billion as of July 16, 2025. Its market cap has increased by 295.28% in one year.
Market Cap
1.19B
Enterprise Value
108.07M
Revenue
63.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.26
Market Cap Chart
Since September 24, 2021, Broncus Holding's market cap has decreased from 7.88B to 1.19B, a decrease of -84.93%. That is a compound annual growth rate of -39.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2025 | 1.19B | 281.88% |
| Dec 31, 2024 | 311.05M | -25.32% |
| Dec 29, 2023 | 416.49M | -65.47% |
| Dec 30, 2022 | 1.21B | -74.55% |
| Dec 31, 2021 | 4.74B | -39.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 232.74B |
| Hansoh Pharmaceutical Group Company | 187.29B |
| Innovent Biologics | 140.17B |
| JD Health International | 136.32B |
| WuXi Biologics | 108.85B |
| Sino Biopharmaceutical | 106.06B |
| Akeso | 101.61B |
| CSPC Pharmaceutical Group | 90.75B |